136
Participants
Start Date
March 31, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
ODM-201
ODM-201 administered orally daily
Brooklyn Urology Research Group, Brooklyn
Chesapeake Urology Research Associates, Baltimore
Carolina Urologic Research Center, Myrtle Beach
Urology Health Team PLLC, Ocala
Cleveland Clinic, Cleveland
The Urology Center of Colorado, Wheat Ridge
Eastern CT Hematology and Oncology Associates, Norwich
Delaware Valley urology, LLC, Voorhees Township
Klinika onkologie a radioterapie LFUK a FN, Hradec Králové
Fakultni Nemonicnice Olomouc, Olomouc
Oddeleni Radiacni a Klinicke Onkologie Nemocnice Znojmo, Znojmo
East-Tallinn Central Hospital, Talinn
Helsinki University Central Hospital, Helsinki
Kuopio University Hospital, Kuopio
Oulu University Hospital, Oulu
Tampere University Hospital, Tampere
Turku University Hospital, Turku
Saint Louis Hospital, Paris
Institut Gustave Roussy, Villejuif
Queen Elizabeth Hospital, Birmingham
Velindre Cancer Centre, Cardiff
Christie Hospital, Manchester
Churchill Hospital, Oxford
Collaborators (1)
Endo Pharmaceuticals
INDUSTRY
Orion Corporation, Orion Pharma
INDUSTRY